Literature DB >> 27304649

Prevalence of common comorbidities among urogynaecological patients.

Tomasz Rechberger1, Łukasz Nowakowski, Ewa Rechberger, Alicja Ziętek, Izabela Winkler, Paweł Miotła.   

Abstract

OBJECTIVES: Due to prolonged life expectancy, regardless of the fact that elderly women are more likely to suffer from comorbidities, urogynaecologists worldwide should expect a growing demand for counseling and effective treatment for patients with pelvic floor defects. The aim of the study was to investigate the incidence of popular comorbidities among urogynaecological patients.
MATERIAL AND METHODS: The retrospective analysis included clinical data of 4,065 consecutive female patients who under-went surgical treatment in the 2nd Department of Gynaecology at the Medical University of Lublin due to urogynaecological disorders between January 2005 and December 2014. Patients were divided into two groups (< 65 years and ≥ 65 years). The vast majority of patients affected by stress urinary incontinence were treated with mid-urethral slings. Most of patients affected by pelvic organ prolapse underwent reconstructive vaginal surgery with reinforcement using anterior and/or pos-terior meshes. Statistical analysis was performed using STATISTICA 10.0 PL (unpaired Student t-test, U Mann Whitney, χ2 test).
RESULTS: In both study groups, overweight and obesity were the most common disorders affecting urogynaecological patients (72.6% overall). Furthermore, the elderly patients suffered more often from the most common comorbidities, such as hypertension (p < 0.01), coronary artery disease (p < 0.001) and diabetes mellitus (p < 0.005).
CONCLUSIONS: Common comorbidities such as overweight and obesity, followed by hypertension and coronary heart diseases, are usual among urogynaecological patients. Changes in lifestyle leading to a decrease in obesity should be considered as an important line treatment when counselling urogynaecological patients.

Entities:  

Keywords:  comorbidities; lower urinary tract symptoms; obesity; pelvic organ prolapse; urinary incontinence

Mesh:

Year:  2016        PMID: 27304649     DOI: 10.5603/GP.2016.0012

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  3 in total

1.  A Novel Research Definition of Bladder Health in Women and Girls: Implications for Research and Public Health Promotion.

Authors:  Emily S Lukacz; Tamara G Bavendam; Amanda Berry; Cynthia S Fok; Sheila Gahagan; Patricia S Goode; Cecilia T Hardacker; Jeni Hebert-Beirne; Cora E Lewis; Jessica Lewis; Lisa Kane Low; Jerry L Lowder; Mary H Palmer; Ariana L Smith; Sonya S Brady
Journal:  J Womens Health (Larchmt)       Date:  2018-05-24       Impact factor: 2.681

2.  Tobacco use, immunosuppressive, chronic pain, and psychiatric conditions are prevalent in women with symptomatic mesh complications undergoing mesh removal surgery.

Authors:  Elliot K Blau; Sarah A Adelstein; Katherine A Amin; Sharon J Durfy; Alvaro Lucioni; Kathleen C Kobashi; Una J Lee
Journal:  Investig Clin Urol       Date:  2019-11-15

3.  A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.

Authors:  Andrzej Wróbel; Aleksandra Szopa; Anna Serefko; Ewa Poleszak
Journal:  Molecules       Date:  2020-03-18       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.